Cita APA

Whittaker, R. G., Blackwood, J. K., Alston, C. L., Blakely, E. L., Elson, J. L., McFarland, R., . . . Taylor, R. W. (2009). URINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE m.3243A>G mtDNA MUTATION. American Academy of Neurology.

Chicago Style Citation

Whittaker, R G., J K. Blackwood, C L. Alston, E L. Blakely, J L. Elson, R. McFarland, P F. Chinnery, D M. Turnbull, i R W. Taylor. URINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE M.3243A>G MtDNA MUTATION. American Academy of Neurology, 2009.

Cita MLA

Whittaker, R G., et al. URINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE M.3243A>G MtDNA MUTATION. American Academy of Neurology, 2009.